Fellowship · Memphis, TN
Sponsored by St Jude Children's Research Hospital
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers.
Nature · 2025 · 225 citations · Helen Heslop
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.
Nature · 2022 · 697 citations · Crystal Mackall
CAR immune cells: design principles, resistance and the next generation.
Nature · 2023 · 559 citations · Crystal Mackall
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas.
Nature · 2025 · 172 citations · Crystal Mackall
The Children's Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers: A Review.
JAMA oncology · 2025 · 126 citations · Matthew Ehrhardt
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.
Transplantation and cellular therapy · 2023 · 331 citations · Aimee Talleur
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial.
Nature medicine · 2021 · 534 citations · Crystal Mackall
Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling.
Science (New York, N.Y.) · 2021 · 538 citations · Crystal Mackall